期刊
WOMENS HEALTH
卷 3, 期 3, 页码 279-290出版社
SAGE PUBLICATIONS LTD
DOI: 10.2217/17455057.3.3.279
关键词
carboplatin; cisplatin; gemcitabine; ovarian cancer; paclitaxel; recurrent ovarian cancer
The US FDA has recently approved the combination of carboplatin and gemcitabine as a second-line therapy for recurrent platinum-sensitive ovarian cancer. This article briefly reviews the pharmacokinetics and mechanism of action of gemcitabine and its synergistic effect with platinum. An overview of the literature on the role of gemcitabine in the treatment of epithelial ovarian cancer is also presented.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据